Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

NCT01955707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: natalizumab
DRUG: Placebo

Sponsor

Biogen